Missouri [US], October 20 (ANI): After 14 months, there is a 70-80 per cent risk that non-small cell lung cancer, one of the two primary types of lung cancer, would become resistant to the pharmacological therapy that was initially used to treat it. There aren't many existing therapy alternatives if it occurs.
Washington [US], July 13 (ANI): Pharmacogenomic testing can help providers avoid prescribing antidepressant medications that may have undesirable outcomes, suggests a new US Department of Veterans Affairs study.
\
\
\
\
